Ownership history in Commodore Capital LP · 7 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in AVALO THERAPEUTICS INC (AVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 483,000 | — | 0% | 0.58% | $8.8M | $18.16 |
| 2025 Q3 | UNCHANGED | 483,000 | — | 0% | 0.30% | $6.1M | $12.71 |
| 2025 Q2 | UNCHANGED | 483,000 | — | 0% | 0.17% | $2.4M | $4.99 |
| 2025 Q1 | UNCHANGED | 483,000 | — | 0% | 0.29% | $3.9M | $8.01 |
| 2024 Q4 | UNCHANGED | 483,000 | — | 0% | 0.26% | $3.6M | $7.43 |
| 2024 Q3 | ADDED | 483,000 | +443,000 | +1107.5% | 0.29% | $4.6M | $9.50 |
| 2024 Q2 | INITIATED | 40,000 | — | — | 0.03% | $499K | — |
As of 2025 Q4 — sorted by position size